Although the consortium to inform molecular and practical approaches to CNS tumor taxonomy-not official WHO (cIMPACT-NOW) recommended a practical diagnostic scheme for diffuse gliomas based on the results of ATRX/p53 immunohistochemistry [16], the ATRX status is only a surrogate and sometimes inconclusive [24]. This evidence concerns the gene ATRX and central nervous system neoplasm.